Back to
Cresset Asset Management, LLC
PVLA
7 quarters
Position history for
Cresset Asset Management, LLC's holdings in Palvella Therapeutics, Inc.
Yes. Cresset holds 11,629 shares of PVLA (Palvella Therapeutics), worth $1.8M, as of its Q2 2026 13F filing. It reduced the position by 231 shares (-2.0%) from Q1 2026. Cresset has held PVLA since Q4 2024, across 7 quarterly 13F filings.
Current Value
$1.8M
Current Shares
11,629
Total Value Change
+$1.5M
Total Shares Change
-9,282
Quarter-by-Quarter History
Other major holders of PVLA: Jennison Associates LLC, BlackRock, Inc., State Street Corp., T. Rowe Price Associates, Inc.